Shareholders Equity ratio Analysis of Acasti Pharma Inc - Deep Dive
WARN : Please note that some of the values may not be in base currency

Shareholders Equity of ACST
Mar-23
85.89
Excellent Shareholders Equity
Mar-22
84.18
Excellent Shareholders Equity
Growth
2.03
%
Shareholders Equity Analysis of Acasti Pharma Inc
Shareholder to Equity Ratio of Acasti Pharma Inc with value of 85.89 indicates that shareholders own a High proportion of the assets of the company.
Shareholders Equity Ratio of ACST has grown by 2.03 % Compared to previous Financial Year.
Shareholders Equity Ratio with value of 89.12 was highest in Year Mar-21 in last Five Years.
Shareholders Equity Ratio with value of 28.80 was lowest in Year Mar-19 in last Five Years.
Latest Shareholders Equity Ratio with value of 85.89 is Greater than Average Shareholders Equity of 68.97 in last five years.
Other Shareholders Equity Related Info of ACST that may interest you.
Acasti Pharma Inc Overview
CodePricePrevious PricePrice ChangeSector
ACST2.692.7599 2.53 % Biotechnology
Fundamental AnalysisTechnical Analysis
Defination of Shareholders Equity
The Shareholders Equity Ratio measures how much the company's assets are funded using shareholder's equity instead of debt. This metric also tells how much shareholders claim on the company's assets in a time of liquidation.    more ..
Shareholders Equity Formula

Shareholders Equity Related Ratios
DebtToEquityRatioReturnOnEquity

Tsr Stability Index
No Significant Stability
FY - Historical Shareholders Equity of Acasti Pharma Inc
PeriodMar-23Mar-22Mar-21Mar-20Mar-19Mar-18Mar-17
Shareholders Equity85.8984.1889.1256.8628.8035.8285.26
Change2.03 %-5.54 %56.73 %97.39 %-19.59 %-57.99 %-10.68 %
You are view first 7 Records. Log in to view all 14 in Premium view
FY Chart of Shareholders Equity of Acasti Pharma Inc


Note : All Data Generated at the End of Trading Hours (EOD Data)